| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.64▲ | 0.64▲ | 0.64▲ | 0.62▲ | 0.62▲ |
| MA10 | 0.65▲ | 0.64▲ | 0.64▲ | 0.62▲ | 0.70▼ |
| MA20 | 0.61▲ | 0.61▲ | 0.61▲ | 0.62▲ | 0.88▼ |
| MA50 | 0.63▲ | 0.64▲ | 0.65▲ | 0.72▼ | 1.26▼ |
| MA100 | 0.68▼ | 0.73▼ | 0.75▼ | 0.93▼ | 2.45▼ |
| MA200 | 0.78▼ | 0.87▼ | 0.88▼ | 1.27▼ | 26.94▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.005▲ | 0.008▲ | 0.009▲ | 0.014▲ | 0.003▲ |
| RSI | 59.034▲ | 58.136▲ | 57.637▲ | 50.799▲ | 35.843▼ |
| STOCH | 50.184 | 60.716 | 60.716 | 61.837 | 15.646▼ |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -16.887▲ | -77.739▼ |
| CCI | 88.330 | 87.227 | 87.227 | 137.070▲ | -79.552 |
|
Monday, December 08, 2025 05:30 AM
Late Breaking Abstract titled "Targeting SCD1 enhances activity of standard of care regorafenib in hepatocellular carcinoma: translational rationale for a phase 1/2 study of the combination of ...
|
|
Friday, November 28, 2025 06:13 AM
(RTTNews) - Galmed Pharmaceuticals Ltd. (GLMD), a clinical-stage biopharmaceutical company, reported a loss in the third quarter loss and also provided updates on its pipeline programs advancing ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/03/26 | 0.63 | 0.692 | 0.63 | 0.66 | 52,029 |
| 05/03/26 | 0.6085 | 0.6402 | 0.59 | 0.63 | 31,847 |
| 04/03/26 | 0.60 | 0.6017 | 0.58 | 0.5876 | 19,156 |
| 03/03/26 | 0.561 | 0.6175 | 0.561 | 0.6111 | 7,655 |
| 02/03/26 | 0.59 | 0.6215 | 0.56 | 0.6175 | 16,408 |
| 27/02/26 | 0.62 | 0.6626 | 0.6103 | 0.6115 | 16,775 |
| 26/02/26 | 0.681 | 0.69 | 0.6459 | 0.65 | 26,784 |
| 25/02/26 | 0.565 | 0.6749 | 0.565 | 0.6616 | 72,219 |
| 24/02/26 | 0.5423 | 0.5826 | 0.53 | 0.575 | 40,056 |
| 23/02/26 | 0.54 | 0.5773 | 0.5025 | 0.5545 | 0 |
|
|
||||
|
|
||||
|
|